Results 261 to 270 of about 32,560 (347)
The Complexities and Challenges of Managing Genetic Causes of Hyperphosphataemia, a Case Report
Journal of Paediatrics and Child Health, EarlyView.
Farrah Rodrigues+3 more
wiley +1 more source
ABSTRACT Background This study investigates the impact of hormone therapy (HT) on the diagnostic performance of 18F‐piflufolastat PET/CT in OSPREY (NCT02981368) cohort B patients with recurrent or metastatic prostate cancer. Methods 18F‐piflufolastat PET/CT was evaluated in OSPREY cohort B patients (n = 117 men) with elevated prostate‐specific antigen (
Lawrence Saperstein+9 more
wiley +1 more source
Paraganglioma of the spermatic cord: A rare tumor with unique imaging findings and diagnostic challenges. [PDF]
Yamamine N+9 more
europepmc +1 more source
Immunohistochemical Evaluation of SARS-CoV-2 Nucleoprotein and ACE2 Markers in Testicular Tumors Diagnosed During the COVID-19 Pandemic. [PDF]
Balcı M, Aydemir Akkaya M.
europepmc +1 more source
Cancer treatment and survivorship statistics, 2025
Abstract The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National ...
Nikita Sandeep Wagle+9 more
wiley +1 more source
Intratesticular lipoma in an elderly patient: A case report. [PDF]
Kavari A+3 more
europepmc +1 more source
Etoposide, a topoisomerase II inhibitor, reduces O‐GlcNAcylation in HepG2 liver cancer cells. Further inhibition of O‐GlcNAc transferase by OSMI‐1 enhanced etoposide‐induced apoptosis, lowering the IC50 for viability and increasing the EC50 for cytotoxicity.
Jaehoon Lee+5 more
wiley +1 more source
Epidermoid cyst arising from the epididymis in a prepubertal boy. [PDF]
Tsutsui K+5 more
europepmc +1 more source
Rare Presentation of Testicular Neoplasm
openaire +2 more sources
Fragment Autoantigens Stimulated T‐Cell‐Immunotherapy (FAST) as a Fast Autologous Cancer Vaccine
A personalized whole tumor cell vaccine (FAST) is developed to address immunosuppressive tumor microenvironments and genomic instability‐driven heterogeneity. Irradiation and cryoablation‐treated tumor cells generate fragmented antigens (FAs) that activate broad‐spectrum antigen presentation via upregulated immunogenic cell death, MHC‐I, and damage ...
Yuan Li+14 more
wiley +1 more source